glp 1 muscle loss and GLP-1R agonists use Normative vs Excess Muscle Loss
Description
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
Type 2 diabetes is driven by a combination of insulin resistance, reduced insulin production over time, and excess glucose output from the liver
Regain risk: Once you stop, appetite usually returns and so does the weight
Behavioral support : Coaching and therapy help address emotional eating, stress triggers, and patterns that can limit progress
doi: 10.1001/jamaoto.2024.4852 [DOI] [PMC free article] [PubMed] [Google Scholar] 32
